REQUEST A DEMO
Total
USD $0.00
Search more companies

UAB Ramuneles Vaistine (Lithuania)

Main Activities: Pharmacies and Drug Stores
Full name: UAB Ramuneles Vaistine Profile Updated: January 01, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Russian Download a sample report

UAB Ramuneles Vaistine is an enterprise in Lithuania, with the main office in Elektrenai. The enterprise currently operates in the Pharmacies and Drug Stores sector. It was incorporated on January 19, 1999. 49 (2025) employees currently work for UAB Ramuneles Vaistine. The company’s latest financial report indicates a net sales revenue increase of 0.69% in 2024. UAB Ramuneles Vaistine’s net profit margin decreased by 4.41% in 2024.

Headquarters
Taikos g. 4-1
Elektrenai; Vilnius county; Postal Code: LT-26112

Contact Details: Purchase the UAB Ramuneles Vaistine report to view the information.

Basic Information
Total Employees:
Purchase the UAB Ramuneles Vaistine report to view the information.
Registered Capital:
Purchase the UAB Ramuneles Vaistine report to view the information.
Financial Auditors:
Purchase the UAB Ramuneles Vaistine report to view the information.
Incorporation Date:
January 19, 1999
Key Executives
Purchase this report to view the information.
Member of the Management Board
Ownership Details
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after UAB Ramuneles Vaistine report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
0.69%
Total operating revenue
0.69%
Net Profit (Loss) for the Period
-213.29%
Total Equity
N/A
Net Profit Margin
-4.41%
Return on Equity (ROE)
N/A

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?